Literature DB >> 22329749

Cadherin binding is not a limiting step for Bacillus thuringiensis subsp. israelensis Cry4Ba toxicity to Aedes aegypti larvae.

Claudia Rodríguez-Almazán1, Esmeralda Z Reyes, Fernando Zúñiga-Navarrete, Carlos Muñoz-Garay, Isabel Gómez, Amy M Evans, Supaporn Likitvivatanavong, Alejandra Bravo, Sarjeet S Gill, Mario Soberón.   

Abstract

Bacillus thuringiensis subsp. israelensis produces three Cry toxins (Cry4Aa, Cry4Ba and Cry11Aa) that are active against Aedes aegypti larvae. The identification of the rate-limiting binding steps of Cry toxins that are used for insect control in the field, such as those of B. thuringiensis subsp. israelensis, should provide targets for improving insecticides against important insect pests. Previous studies showed that Cry11Aa binds to cadherin receptor fragment CR7-11 (cadherin repeats 7-11) with high affinity. Binding to cadherin has been proposed to facilitate Cry toxin oligomer formation. In the present study, we show that Cry4Ba binds to CR7-11 with 9-fold lower binding affinity compared with Cry11Aa. Oligomerization assays showed that Cry4Ba is capable of forming oligomers when proteolytically activated in vitro in the absence of the CR7-11 fragment in contrast with Cry11Aa that formed oligomers only in the presence of CR7-11. Pore-formation assays in planar lipid bilayers showed that Cry4Ba oligomers were proficient in opening ion channels. Finally, silencing the cadherin gene by dsRNA (double-stranded RNA) showed that silenced larvae were more tolerant to Cry11Aa in contrast with Cry4Ba, which showed similar toxic levels to those of control larvae. These findings show that cadherin binding is not a limiting step for Cry4Ba toxicity to A. aegypti larvae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329749      PMCID: PMC3686486          DOI: 10.1042/BJ20111579

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Cadherin-like receptor binding facilitates proteolytic cleavage of helix alpha-1 in domain I and oligomer pre-pore formation of Bacillus thuringiensis Cry1Ab toxin.

Authors:  Isabel Gómez; Jorge Sánchez; Raúl Miranda; Alejandra Bravo; Mario Soberón
Journal:  FEBS Lett       Date:  2002-02-27       Impact factor: 4.124

2.  Crystal structure of the mosquito-larvicidal toxin Cry4Ba and its biological implications.

Authors:  Panadda Boonserm; Paul Davis; David J Ellar; Jade Li
Journal:  J Mol Biol       Date:  2005-04-29       Impact factor: 5.469

Review 3.  Mode of action of Bacillus thuringiensis Cry and Cyt toxins and their potential for insect control.

Authors:  Alejandra Bravo; Sarjeet S Gill; Mario Soberón
Journal:  Toxicon       Date:  2006-11-30       Impact factor: 3.033

4.  Bacillus thuringiensis ssp. israelensis Cyt1Aa enhances activity of Cry11Aa toxin by facilitating the formation of a pre-pore oligomeric structure.

Authors:  Claudia Pérez; Carlos Muñoz-Garay; Leivi C Portugal; Jorge Sánchez; Sarjeet S Gill; Mario Soberón; Alejandra Bravo
Journal:  Cell Microbiol       Date:  2007-08-02       Impact factor: 3.715

Review 5.  Role of receptors in Bacillus thuringiensis crystal toxin activity.

Authors:  Craig R Pigott; David J Ellar
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

6.  Specific epitopes of domains II and III of Bacillus thuringiensis Cry1Ab toxin involved in the sequential interaction with cadherin and aminopeptidase-N receptors in Manduca sexta.

Authors:  Isabel Gómez; Iván Arenas; Itzel Benitez; Juan Miranda-Ríos; Baltazar Becerril; Ricardo Grande; Juan Carlos Almagro; Alejandra Bravo; Mario Soberón
Journal:  J Biol Chem       Date:  2006-09-12       Impact factor: 5.157

7.  Oligomerization triggers binding of a Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N receptor leading to insertion into membrane microdomains.

Authors:  A Bravo; I Gómez; J Conde; C Muñoz-Garay; J Sánchez; R Miranda; M Zhuang; S S Gill; M Soberón
Journal:  Biochim Biophys Acta       Date:  2004-11-17

8.  High-level cryIVD and cytA gene expression in Bacillus thuringiensis does not require the 20-kilodalton protein, and the coexpressed gene products are synergistic in their toxicity to mosquitoes.

Authors:  C Chang; Y M Yu; S M Dai; S K Law; S S Gill
Journal:  Appl Environ Microbiol       Date:  1993-03       Impact factor: 4.792

9.  Tryptophan spectroscopy studies and black lipid bilayer analysis indicate that the oligomeric structure of Cry1Ab toxin from Bacillus thuringiensis is the membrane-insertion intermediate.

Authors:  Carolina Rausell; Carlos Muñoz-Garay; Raúl Miranda-CassoLuengo; Isabel Gómez; Enrique Rudiño-Piñera; Mario Soberón; Alejandra Bravo
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

10.  Cadherin fragments from Anopheles gambiae synergize Bacillus thuringiensis Cry4Ba's toxicity against Aedes aegypti larvae.

Authors:  Youngjin Park; Gang Hua; Mohd Amir F Abdullah; Khalidur Rahman; Michael J Adang
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

View more
  18 in total

1.  Aedes aegypti alkaline phosphatase ALP1 is a functional receptor of Bacillus thuringiensis Cry4Ba and Cry11Aa toxins.

Authors:  Alan I Jiménez; Esmeralda Z Reyes; Angeles Cancino-Rodezno; Leidy P Bedoya-Pérez; Gustavo G Caballero-Flores; Luis F Muriel-Millan; Supaporn Likitvivatanavong; Sarjeet S Gill; Alejandra Bravo; Mario Soberón
Journal:  Insect Biochem Mol Biol       Date:  2012-06-20       Impact factor: 4.714

2.  Aedes cadherin mediates the in vivo toxicity of the Cry11Aa toxin to Aedes aegypti.

Authors:  Su-Bum Lee; Jianwu Chen; Karlygash G Aimanova; Sarjeet S Gill
Journal:  Peptides       Date:  2014-07-23       Impact factor: 3.750

3.  An Intramolecular Salt Bridge in Bacillus thuringiensis Cry4Ba Toxin Is Involved in the Stability of Helix α-3, Which Is Needed for Oligomerization and Insecticidal Activity.

Authors:  Sabino Pacheco; Isabel Gómez; Jorge Sánchez; Blanca-Ines García-Gómez; Mario Soberón; Alejandra Bravo
Journal:  Appl Environ Microbiol       Date:  2017-09-29       Impact factor: 4.792

4.  Functional characterization of Aedes aegypti alkaline phosphatase ALP1 involved in the toxicity of Cry toxins from Bacillus thuringiensis subsp. israelensis and jegathesan.

Authors:  Jianwu Chen; Karly Aimanova; Sarjeet S Gill
Journal:  Peptides       Date:  2017-06-03       Impact factor: 3.750

5.  Potential Prepore Trimer Formation by the Bacillus thuringiensis Mosquito-specific Toxin: MOLECULAR INSIGHTS INTO A CRITICAL PREREQUISITE OF MEMBRANE-BOUND MONOMERS.

Authors:  Wilaiwan Sriwimol; Aratee Aroonkesorn; Somsri Sakdee; Chalermpol Kanchanawarin; Takayuki Uchihashi; Toshio Ando; Chanan Angsuthanasombat
Journal:  J Biol Chem       Date:  2015-06-25       Impact factor: 5.157

6.  Alkaline phosphatases and aminopeptidases are altered in a Cry11Aa resistant strain of Aedes aegypti.

Authors:  Su-Bum Lee; Karlygash G Aimanova; Sarjeet S Gill
Journal:  Insect Biochem Mol Biol       Date:  2014-09-19       Impact factor: 4.714

7.  A toxin-binding alkaline phosphatase fragment synergizes Bt toxin Cry1Ac against susceptible and resistant Helicoverpa armigera.

Authors:  Wenbo Chen; Chenxi Liu; Yutao Xiao; Dandan Zhang; Yongdong Zhang; Xianchun Li; Bruce E Tabashnik; Kongming Wu
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Bacillus thuringiensis Cry1A toxins are versatile proteins with multiple modes of action: two distinct pre-pores are involved in toxicity.

Authors:  Isabel Gómez; Jorge Sánchez; Carlos Muñoz-Garay; Violeta Matus; Sarjeet S Gill; Mario Soberón; Alejandra Bravo
Journal:  Biochem J       Date:  2014-04-15       Impact factor: 3.857

Review 9.  Bacillus thuringiensis subsp. israelensis and its dipteran-specific toxins.

Authors:  Eitan Ben-Dov
Journal:  Toxins (Basel)       Date:  2014-03-28       Impact factor: 4.546

10.  Electrical hypothesis of toxicity of the Cry toxins for mosquito larvae.

Authors:  Victor V Lemeshko; Sergio Orduz
Journal:  Biosci Rep       Date:  2013-01-11       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.